fujirebio - Search News

Order byBest matchMost fresh

News

Alzheimer's, FDA and Fujirebio

FDA approves Fujirebio’s Lumipulse as first Alzheimer’s disease blood test

The US Food and Drug Administration (FDA) has approved Fujirebio Diagnostics’ Alzheimer’s disease (AD) blood test to help detect the neurodegenerative disease earlier. The decision makes the diagnostic device, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, the first AD blood test to be cleared by the regulator.

Continue reading

BioWorld · 16h

Fujirebio Alzheimer’s test wins first FDA clearance

Best Life on MSN · 21h

FDA Approves First-Ever Alzheimer's Blood Test—Here's Who Will Benefit

2hon MSN

First blood test for Alzheimer’s to be available in U.S. in June

The Food and Drug Administration has cleared the blood test to help diagnose Alzheimer's disease, potentially making it ...

Breakthrough Alzheimer's blood test has been approved for the US

The very first blood test for Alzheimer's disease detection has been green-lit by the US Food and Drug Administration (FDA), ...

MyChesCo on MSN3d

Fujirebio and AriBio Achieve Milestone in Biomarker Advancement for Alzheimer’s Disease

Fujirebio Holdings Inc., its subsidiary Fujirebio Diagnostics, Inc., and AriBio Co., Ltd. have announced the successful ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results